Myriad Genetics, Inc.

NASDAQ: MYGN    
Share price (5/1/24): $19.47    
Market cap (5/1/24): $1.762 billion
Search in Documents
Key Exhibits
External Links
6 Myriad Genetics, Inc. Expert Interviews, now on BamSEC.
 Powered by Tegus.

Material Contracts Filter

EX-10.19
from 10-K 12 pages Separation and Consulting Agreement and Release of Claims
12/34/56
EX-10.18
from 10-K 11 pages Separation and Consulting Agreement and Release of Claims
12/34/56
EX-10.17
from 10-K 12 pages Executive Employment Agreement
12/34/56
EX-10.16
from 10-K 10 pages Severance and Change of Control Agreement
12/34/56
EX-10.5
from 10-K 83 pages Nexus on Grand Lease
12/34/56
EX-10.4
from 10-K 105 pages Lease 322 North 2200 West (Building D) Salt Lake City, Utah Lessor: Bay Bridge/Corporate, LLC Lessee: Myriad Genetics, Inc
12/34/56
EX-10.3
from 10-K 4 pages Lease Termination Agreement
12/34/56
EX-10.2
from 10-K 4 pages Lease Termination Agreement
12/34/56
EX-10.1
from 10-K 5 pages Lease Termination Agreement
12/34/56
EX-10.2
from 10-Q 9 pages Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 3 pages Material contract
12/34/56
EX-10.1
from 8-K 11 pages Separation and Consulting Agreement and Release of Claims
12/34/56
EX-10.4
from 10-Q 2 pages Myriad Genetics, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.2
from 8-K 32 pages Pledge and Security Agreement
12/34/56
EX-10.1
from 10-Q 7 pages Myriad Genetics, Inc. Restricted Stock Unit Agreement - Incorporated Terms and Conditions
12/34/56
EX-10.2
from 10-Q 2 pages Myriad Genetics, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.1
from 8-K 9 pages Myriad Genetics, Inc. Amended and Restated 2012 Employee Stock Purchase Plan
12/34/56
EX-10.1
from 8-K 12 pages Separation and Consulting Agreement
12/34/56
EX-10.1
from 10-Q 9 pages Myriad Genetics, Inc. Amended and Restated 2012 Employee Stock Purchase Plan
12/34/56
EX-10.8
from 10-KT 2 pages Myriad Genetics, Inc. Non-Employee Director Compensation Policy
12/34/56